Insider Transactions in Q4 2022 at Outlook Therapeutics, Inc. (OTLK)
Insider Transaction List (Q4 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 28
2022
|
Ghiath M. Sukhtian Director |
BUY
Grant, award, or other acquisition
|
Indirect |
14,230,418
+16.89%
|
$0
$0.88 P/Share
|
|
Oct 07
2022
|
Faisal Ghiath Sukhtian |
BUY
Open market or private purchase
|
Direct |
30,000
+30.61%
|
$30,000
$1.29 P/Share
|
|
Oct 07
2022
|
Yezan Munther Haddadin |
BUY
Open market or private purchase
|
Direct |
3,600
+5.38%
|
$3,600
$1.27 P/Share
|
|
Oct 06
2022
|
Yezan Munther Haddadin |
BUY
Open market or private purchase
|
Direct |
29,743
+33.24%
|
$29,743
$1.29 P/Share
|
|
Oct 05
2022
|
Kurt J Hilzinger |
BUY
Open market or private purchase
|
Direct |
15,662
+3.2%
|
$15,662
$1.23 P/Share
|
|
Oct 04
2022
|
Kurt J Hilzinger |
BUY
Open market or private purchase
|
Direct |
95,541
+17.28%
|
$95,541
$1.29 P/Share
|
|
Oct 03
2022
|
Kurt J Hilzinger |
BUY
Open market or private purchase
|
Direct |
41,798
+10.35%
|
$41,798
$1.25 P/Share
|